A previous study demonstrated that GBM tumors extensively infiltrated immunosuppressive CD68+ macrophage populations, which were coexpressed with PD-L1, and that low expression levels of CD3+ T-cell populations compromised GBM prognosis [44]. The gene discussed is CD68; the disease is glioblastoma.